Kevin Kos

Kevin Kos is currently serving as a Programmacoördinator Immunotherapie at KWF Kankerbestrijding since August 2022. Prior experience includes a PhD Candidate position in Tumor Immunology at The Netherlands Cancer Institute from October 2016 to May 2022, where Kevin managed a project on regulatory T cells in breast cancer under the supervision of Professor Karin de Visser. Kevin's earlier research internships include a significant role at QIMR Berghofer Medical Research Institute, focusing on NK cell migration and tumor surveillance, as well as positions at The Netherlands Cancer Institute and ACTA, investigating chemo-resistance and cariogenic potential, respectively. Kevin holds a Master's degree in Oncology and a Bachelor's degree in Biomedical Sciences from Vrije Universiteit Amsterdam, in addition to a VWO diploma in Nature & Health from Erfgooiers College Huizen.